
PRIX GALIEN UK
The 2025 edition of the Prix Galien UK Forum & Awards Ceremony was held on Thursday, 5 June in London
Leading global and international figures in life science research, development, regulation, and incentivisation met at the Prix Galien forum event in London, United Kingdom to engage in conversations about the most burning challenges to improving the human condition worldwide. The gathering was followed by the prestigious Prix Galien UK Awards, honouring the most remarkable "made in the UK" life science innovations. The awards acknowledged excellence in categories of Best Biotechnology Product, Best Digital Health Solution, Best Medical Technology, Best Pharmaceutical Product, Best Public Sector Innovation and Best Health Equity Innovation.
Highlights from the 2025 Prix Galien UK Forum & Awards

Prof. Sir Munir PIRMOHAMED
Prix Galien UK Committee Chair
Best Pharmaceutical Product
LYNPARZA® by AstraZeneca and Merck Sharp & Dohme (MSD)
Best Pharmaceutical Product (Orphan/Rare Disease Indication)
Rezurock (Belumosudil) by Sanofi
Best Biotechnology Product
KIMMTRAK® by Immunocore
Best Medical Technology
Omnipod® 5 Automated Insulin Delivery System by Insulet Corporation
Best Digital Health Solution
KIDNEY BEAM by Kidney Beam Ltd.
Best Public Sector Innovation
Oxford R21/Matrix-M™ Malaria Vaccine by University of Oxford
Best Health Equity Initiative
Solar Surgery by Kids Operating Room
Committee Member Prof. Duncan Richards (r) with 2025 Best Pharmaceutical Product Winner
“This year's submissions were of exceptional caliber, making the task of selecting winners both challenging and inspiring. The awardees have demonstrated groundbreaking progress in their fields, and their work holds great promise for patients worldwide," said Professor Sir Munir Pirmohamed, David Weatherall Chair of Medicine at the University of Liverpool, NHS Chair of Pharmacogenetics, and Chair of the Prix Galien UK Committee.

The prestigious 2025 Prix Galien UK Lifetime Achievement Award was bestowed upon Dame June Raine, Former Chief Executive Officer, Medicines and Healthcare Products Regulatory Agency, for outstanding contributions to the UK health industry.
Preceding the Awards Ceremony, the Prix Galien UK Forum brought forth a day-long exchange on the most significant challenges facing humanity in the realm of disease while highlighting the latest research and clinical pathways toward diagnosis, treatment, and cure. Among the topics discussed in the 2025 edition of the forum:
- How will joint clinical assessments impact patient access to medicines in Europe?
- Are breakthrough therapies for ultra rare diseases within reach?
- Global Challenges and Opportunities for Prevention and Population Health
-
How can healthcare systems deliver solutions at scale to address the global mental health crisis?
2025 Prix Galien UK Forum - Panel 1
The Prix Galien UK judging panel comprises numerous of the UK’s leading luminaries in healthcare. The distinguished panel is guided by the conviction that acknowledging research-driven innovation is key to the improvement of healthcare in the UK and human health globally.
A DISTINGUISHED PANEL OF PEERS

Prof. Sir Munir PIRMOHAMED (Committee Chair)

Prof. Jane ADAM

Prof. Bruce CAMPBELL

Prof. Jesse DAWSON

Dr. Stephanie KUKU

Prof. Sudhesh KUMAR

Prof. Andrew MORRIS

Prof. Sharon PEACOCK

Dame June RAINE

Prof. Duncan RICHARDS

Prof. Lauren WALKER

Dame Moira WHYTE
A WORD FROM THE JUDGING COMMITTEE
FOUNDING PRIX GALIEN UK COMMITTEE CHAIR

As a Founding Prix Galien UK Committee Chair, Professor Sir Mike Rawlins worked closely with the Prix Galien for over 20 years and acted as the Chair of the judging committee. In this video he explains the value of recognising innovation within the pharmaceutical and medtech industries and gives an insight into why he valued the Prix Galien so highly.
Watch the videoPRIX GALIEN UK FORUM
